How many institutions held HCAT - Health Catalyst, Inc. - Common Stock, par value $0.001 per share in Q3 2025?

142 institutional investors reported HCAT - Health Catalyst, Inc. - Common Stock, par value $0.001 per share for Q3 2025. Use the holders table for investor-level position and value details.

Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT)

Q: What does CUSIP 42225T107 represent in this 13F holders report?

CUSIP 42225T107 is the security identifier for HCAT - Health Catalyst, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 42225T107

Q3 2025 13F Holders as of 30 Sep 2025

Security type / class: Equity / Common Stock, par value $0.001 per share
Total 13F shares: 54,134,724
Total 13F value: $154,287,158
Share change: -117,586
Put/Call ratio: 1601%
SEC-reported price per share: $2.85
Number of holders: 142
Value change: -$4,573,641
Number of buys: 72
Number of sells: 72
Shares outstanding: 73,911,438

Security key

42225T107

Report period

Q3 2025

Institutions

142

Top holders

HCAT full security history Ownership snapshot Full 13F holder table Health Catalyst, Inc. SEC filings Health Catalyst, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of HCAT - Health Catalyst, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

David Coy Ross

Disclosed value leader

First Light Asset Managem...

Comparable rows

15/15

Latest evidence

02 Sep 2025

3/4/5 13F Lead comparable stake: 0.28% Showing 1-6 of 15 holder rows.

Quick read

David Coy Ross leads the comparable SEC ownership view at 0.28%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens David Coy Ross's linked filing trail.

Comparable ownership Top 5

David Coy Ross 0.28%

Daniel LeSueur 0.27%

KANE JOHN A 0.23%

S. Dawn Smith 0.14%

First Light Asset Management, LLC 17%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
David Coy Ross	3/4/5 Chief Tech & Product Officer 3/4/5	0.28%	$686,727 204,219 shares	—	02 Sep 2025
Daniel LeSueur	3/4/5 Chief Operating Officer 3/4/5	0.27%	$667,048 198,367 shares	—	02 Sep 2025
KANE JOHN A	3/4/5 Director 3/4/5	0.23%	$643,610 170,719 shares	—	09 Jul 2025
S. Dawn Smith	3/4/5 Director 3/4/5	0.14%	$383,378 101,692 shares	—	09 Jul 2025
First Light Asset Management, LLC	13F Company 13F	17%	$46,107,782 12,230,181 shares	—	30 Jun 2025
BlackRock, Inc.	13F Company 13F	7.6%	$21,306,430 5,651,573 shares	—	30 Jun 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

142

54,134,724

Rows available

142

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders

144

Q3 2025 holders

142

Holder diff

-2

Investor	Q2 2025 Shares	Q3 2025 Shares	Share Diff	Share Chg %	Q2 2025 value	Q3 2025 value	Value change	Value Chg %